Standing Committee on Biotechnology Capabilities and National Security Needs
Agency: Washington Headquarters Services
- 12.599 -- Congressionally Directed Assistance
Archived opportunityLast Updated: May 13, 2026
View version history on Grants.gov
Description
The National Commission on Emerging Biotechnology requests that the National Academy of Science address the following topics under the auspices of the Standing Committee on Biotechnology Capabilities and National Security Needs and associated ad hoc consensus study Committee on Biotechnology Capabilities for National Security Needs:
• Enduring capability for identifying and assessing over-the-horizon biotechnology development.
• Innovative approach to evaluating traditional and non-traditional applications of emerging biotechnologies.
• Successful methods for communicating national security needs and requirements to industry and academia
• Exemplars of effective and ineffective regulatory processes enabling biotechnology transfer between government and commercial entities.
The committees will use AI/ML and experimental/laboratory automation in biotechnology research and development as specific examples as they discuss the more expansive topics.
Eligibility
Eligible applicants
Miscellaneous
- Other
Additional information
Grantor contact information
Description
Grants Officer
Documents
| File name | Description | Last updated |
|---|---|---|
| G03_SCBC_NAS_NFO_.pdf | NFO | Sep 5, 2023 06:38 PM UTC |
| G03_Attachment_0001_SOW_Final.pdf | SOW | Sep 5, 2023 06:41 PM UTC |
Link to additional information
--
Archived: October 12, 2023
Award
$700,000
Program Funding
1
Expected awards
$--
Award Minimum
$700,000
Award Maximum
Funding opportunity number:
HQ003423NFOEASD18
Cost sharing or matching requirement:
Funding instrument type:
Grant
Opportunity Category:
Discretionary
Opportunity Category Explanation:
Category of Funding Activity:
Science technology and other research and development
Category Explanation:
History
Version:
1
Posted date:
September 5, 2023
Archive date:
October 12, 2023
